Lind Global Fund III LP

13F Holdings History for Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Symbol: SLXN on Nasdaq
Investment type: Equity / Ordinary shares, par value $0.0135 per share
Latest Disclosed Ownership: 213K shares
Security Ownership: 6.4%

Lind Global Fund III LP ownership in Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN)

2025-11-14 - Lind Global Fund III LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 213K shares of Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN). This represents 6.4% percent ownership of the company. In their previous filing dated 2025-09-18, Lind Global Fund III LP had reported owning 224K shares, indicating a decrease of -5.16% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Lind Global Fund III LP	6.4%	-35%	$187K	213K	-11,550	-5.16%	$0.88	13G/A	9/30/2025	14 Nov 2025 16:09:41
Lind Global Fund III LP	9.9%		$197K	224K			$0.88	13G	9/12/2025	18 Sep 2025 17:47:12